Calcium channels and calcium channel antagonists

Changes in free intracellular Ca2+ levels provide signals that allow nerve and muscle cells to respond to a host of external stimuli. A major mechanism for elevating the level of intracellular Ca2+ is the influx of extracellular Ca2+ through voltage‐dependent channels in the cell membrane. Recent research has yielded new insights into the physiological properties, molecular structure, biochemical regulation, and functional heterogeneity of voltage‐dependent Ca2+ channels. In addition, Ca2+ channel antagonist drugs have been developed that are valuable both as probes of channel structure and function and as therapeutic agents. Preliminary evidence suggests that these drugs may be useful in the treatment of diverse neurological disorders, including headache, subarachnoid hemorrhage, stroke, and epilepsy.

[1]  D. Greenberg,et al.  Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists. , 1985, The Journal of pharmacology and experimental therapeutics.

[2]  M. Bechem,et al.  The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. , 1985, European journal of pharmacology.

[3]  D. Greenberg,et al.  Stimulation of Calcium Uptake in PC12 Cells by the Dihydropyridine Agonist BAY K 8644 , 1985, Journal of neurochemistry.

[4]  H. Lux,et al.  A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones , 1984, Nature.

[5]  F. Hofmann,et al.  Injection of subunits of cyclic AMP-dependent protein kinase into cardiac myocytes modulates Ca2+ current , 1982, Nature.

[6]  P. Kostyuk,et al.  Calcium channels in the somatic membrane of the rat dorsal root ganglion neurons, effect of cAMP , 1981, Brain Research.

[7]  B. Hille.  Ionic channels of excitable membranes , 2001 .

[8]  H. J. Gelmers.  Nimodipine, a New Calcium Antagonist, in the Prophylactic Treatment of Migraine , 1983, Headache.

[9]  M. Lazdunski,et al.  Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K8644) and inhibitor (PN 200-110). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Beart,et al.  Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations. , 1984, European journal of pharmacology.

[11]  Beller He.  Letter: Pulmonary oedema. , 1976 .

[12]  H. Krause,et al.  Behavioral effects of nimodipine in animals. , 1982, Arzneimittel-Forschung.

[13]  W. Amery,et al.  Flunarizine, a Calcium Entry Blocker in Migraine Prophylaxis , 1985, Headache.

[14]  G. Solomon,et al.  Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. , 1983, JAMA.

[15]  J. Wood,et al.  Polyclonal antibodies to phospholipid/Ca2+-dependent protein kinase and immunocytochemical localization of the enzyme in rat brain. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Krause,et al.  Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs. , 1983, Annals of emergency medicine.

[17]  R. Tsien,et al.  A novel type of cardiac calcium channel in ventricular cells , 1985, Nature.

[18]  R Llinás,et al.  Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Schoemaker,et al.  Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. , 1984, The Journal of pharmacology and experimental therapeutics.

[20]  S. Freedman,et al.  Are dihydropyridine binding sites voltage sensitive calcium channels? , 1984, Life sciences.

[21]  H. Glossmann,et al.  Novel 1,4‐Dihydropyridine (Bay K 8644) Facilitates Calcium‐Dependent [3H]Noradrenaline Release from PC 12 Cells , 1984, Journal of neurochemistry.

[22]  H. Motulsky,et al.  Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors. , 1985, The New England journal of medicine.

[23]  B. Katzung,et al.  Diltiazem and verapamil preferentially block inactivated cardiac calcium channels. , 1983, Journal of molecular and cellular cardiology.

[24]  J. Jass,et al.  A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER , 1987, The Lancet.

[25]  C. Kumana,et al.  BIZARRE PERCEPTUAL DISORDER OF EXTREMITIES IN PATIENTS TAKING VERAPAMIL , 1981, The Lancet.

[26]  K. Rahn,et al.  Reduction of bioavailability of verapamil by rifampin. , 1985, The New England journal of medicine.

[27]  R. Smith,et al.  Diltiazem prophylaxis in refractory migraine. , 1984, The New England journal of medicine.

[28]  N. Davidson,et al.  Expression and modulation of voltage-gated calcium channels after RNA injection in Xenopus oocytes. , 1986, Science.

[29]  F. Hofmann,et al.  Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel , 1986, Nature.

[30]  S. Snyder,et al.  Calcium antagonists receptor sites labeled with [3H]nitrendipine , 1982 .

[31]  H. Glossmann,et al.  [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. , 1982, Arzneimittel-Forschung.

[32]  R. Kelly,et al.  A molecular description of nerve terminal function. , 1983, Annual review of biochemistry.

[33]  D. Greenberg,et al.  Lectin‐Induced Enhancement of Voltage‐Dependent Calcium Flux and Calcium Channel Antagonist Binding , 1987, Journal of neurochemistry.

[34]  D. Nachshen.  The early time course of potassium‐stimulated calcium uptake in presynaptic nerve terminals isolated from rat brain. , 1985, Journal of Physiology.

[35]  C. R. Ingram,et al.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. , 1983, The New England journal of medicine.

[36]  R. Pozos,et al.  Electrophysiologic effects of acute ethanol exposure. I. Alterations in the action potentials of dorsal root ganglia neurons in dissociated culture. , 1982, Brain research.

[37]  W. Colucci,et al.  An increase in putative voltage dependent calcium channel number following reserpine treatment. , 1985, Biochemical and biophysical research communications.

[38]  R. Farrar,et al.  Inhibition of fast- and slow-phase depolarization-dependent synaptosomal calcium uptake by ethanol. , 1983, The Journal of pharmacology and experimental therapeutics.

[39]  M. Sanguinetti,et al.  Regulation of cardiac calcium channel current and contractile activity by the dihydropyridine Bay K 8644 is voltage-dependent. , 1984, Journal of molecular and cellular cardiology.

[40]  P. Gean,et al.  Calcitonin and calcitonin gene-related peptide enhance calcium-dependent potentials , 1986, Brain Research.

[41]  M. Winniford,et al.  Calcium Antagonists in Patients with Cardiovascular Disease: CURRENT PERSPECTIVES , 1985, Medicine.

[42]  S. Snyder,et al.  Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects. , 1984, The Journal of pharmacology and experimental therapeutics.

[43]  R. Tsien,et al.  Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells , 1983, Nature.

[44]  R S Zucker,et al.  Relationship between transmitter release and presynaptic calcium influx when calcium enters through discrete channels. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Creba,et al.  The effect of dihydropyridine calcium agonists and antagonists on neuronal voltage sensitive calcium channels. , 1986, Biochemical and biophysical research communications.

[46]  M. Sanguinetti,et al.  Voltage‐Dependent Block of Calcium Channel Current in the Calf Cardiac Purkinje Fiber by Dihydropyridine Calcium Channel Antagonists , 1984, Circulation research.

[47]  D. Greenberg,et al.  Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line. , 1987, Cancer research.

[48]  M. Lazdunski,et al.  Short term and long term effects of beta-adrenergic effectors and cyclic AMP on nitrendipine-sensitive voltage-dependent Ca2+ channels of skeletal muscle. , 1985, The Journal of biological chemistry.

[49]  D. Greenberg,et al.  Phenytoin interacts with calcium channels in brain membrances , 1984 .

[50]  Y. Sasaguri,et al.  IMMUNE COMPLEX AND MITE ANTIGEN IN KAWASAKI DISEASE , 1982, The Lancet.

[51]  H. Reuter.  Calcium channel modulation by neurotransmitters, enzymes and drugs , 1983, Nature.

[52]  Publicover Sj,et al.  Stimulation of spontaneous transmitter release by the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, an activator of protein kinase C. , 1985 .

[53]  Stephen J. Smith,et al.  NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones , 1986, Nature.

[54]  E. Costa,et al.  Dihydropyridines change the uptake of calcium induced by depolarization into primary cultures of cerebellar granule cells , 1985, Neuropharmacology.

[55]  K. Dunlap,et al.  Kinase C activator 1,2-oleoylacetylglycerol attenuates voltage-dependent calcium current in sensory neurons. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Walsh.  Calcium Regulation of Smooth Muscle Contraction , 1985 .

[57]  D. Greenberg,et al.  Ethanol regulates calcium channels in clonal neural cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. W. Leslie,et al.  45Ca2+ Uptake into Rat Whole Brain Synaptosomes Unaltered by Dihydropyridine Calcium Antagonists , 1983, Journal of neurochemistry.

[59]  S. Rapoport,et al.  Blockers of calcium permeability inhibit neurite extension and formation of neuromuscular synapses in cell culture. , 1984, Brain research.

[60]  H. Glossmann,et al.  Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4‐dihydropyridine photoaffinity probe, [3H]azidopine. , 1985, The EMBO journal.

[61]  E. Costa,et al.  Different coupling of excitatory amino acid receptors with Ca2+ channels in primary cultures of cerebellar granule cells , 1985, Neuropharmacology.

[62]  W. Catterall,et al.  Phosphorylation of the calcium antagonist receptor of the voltage-sensitive calcium channel by cAMP-dependent protein kinase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[63]  G. Lnenicka,et al.  Structure and function in synapses: emerging correlations , 1986, Trends in Neurosciences.

[64]  M. Lazdunski,et al.  The 1,4-dihydropyridine receptor associated with the skeletal muscle voltage-dependent Ca2+ channel. Purification and subunit composition. , 1985, The Journal of biological chemistry.

[65]  R. Zucker,et al.  Mechanism of transmitter release: voltage hypothesis and calcium hypothesis. , 1986, Science.

[66]  Richard J. Miller.  How many types of calcium channels exist in neurones? , 1985, Trends in Neurosciences.

[67]  L. Auer,et al.  Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms. , 1984, Neurosurgery.

[68]  D. Greenberg,et al.  Calcium channel ‘agonist’ BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes , 1984, Brain Research.

[69]  S. Snyder,et al.  Calcium Channel Blockade: Possible Explanation for Thioridazine's Peripheral Side Effects , 1984 .

[70]  S. Snyder,et al.  A unitary mechanism of calcium antagonist drug action. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Holz,et al.  GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels , 1986, Nature.

[72]  G. Allen,et al.  The calcium antagonist properties of cyproheptadine , 1984, Neurology.

[73]  S. Snyder,et al.  (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. , 1986, The Journal of pharmacology and experimental therapeutics.

[74]  M. Schramm,et al.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels , 1983, Nature.

[75]  A. Schwartz.  Neurological recovery after cardiac arrest: clinical feasibility trial of calcium blockers. , 1985, The American journal of emergency medicine.

[76]  R. Macdonald,et al.  Adenosine agonists reduce voltage‐dependent calcium conductance of mouse sensory neurones in cell culture. , 1986, The Journal of physiology.

[77]  J. Woodward,et al.  Bay K 8644 stimulation of calcium entry and endogenous dopamine release in rat striatal synaptosomes antagonized by nimodipine , 1986, Brain Research.

[78]  M. Sanguinetti,et al.  Calcium channel agonist and antagonist effects of the stereoisomers of the dihydropyridine 202-791. , 1985, Biochemical and biophysical research communications.

[79]  R. Harris,et al.  Alcohols and synaptosomal calcium transport. , 1982, Molecular pharmacology.

[80]  C. Binnie,et al.  Double‐Blind Placebo‐Controlled Trial of Flunarizine as Add‐on Therapy in Epilepsy , 1984, Epilepsia.

[81]  Peter Hess,et al.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists , 1984, Nature.

[82]  P. Nelson,et al.  Effects of nitrendipine on the voltage‐sensitive calcium channel in mammalian sensory neurons , 1985, Journal of neuroscience research.

[83]  R. Loutzenhiser,et al.  Mechanisms of calcium antagonist-induced vasodilation. , 1983, Annual review of pharmacology and toxicology.

[84]  G. Fischbach,et al.  Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. , 1981, The Journal of physiology.

[85]  D. Middlemiss,et al.  A functional correlate for the dihydropyridine binding site in rat brain , 1985, Nature.

[86]  D. Warltier,et al.  Slow channel calcium activators, a new group of pharmacological agents. , 1985, Life sciences.

[87]  J. Louvel,et al.  Fast extracellular calcium transients: involvement in epileptic processes. , 1983, Science.

[88]  P. Gygax,et al.  Calcium Antagonist PY 108-068: Demonstration of Its Efficacy in Various Types of Experimental Brain Ischemia , 1984, Stroke.

[89]  M. Nelson,et al.  Single nisoldipine-sensitive calcium channels in smooth muscle cells isolated from rabbit mesenteric artery. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[90]  A Grinvald,et al.  Localization of voltage-sensitive calcium channels along developing neurites: their possible role in regulating neurite elongation. , 1982, Developmental biology.

[91]  N. Zisapel,et al.  Calcium permeability changes and neurotransmitter release in cultured rat brain neurons. I. Effects of stimulation on calcium fluxes. , 1985, The Journal of biological chemistry.

[92]  J. Farley,et al.  Protein kinase C activation induces conductance changes in Hermissenda photoreceptors like those seen in associative learning , 1986, Nature.

[93]  J. Cheronis,et al.  Verapamil in prophylactic therapy of migraine , 1984, Neurology.

[94]  V. Ramkumar,et al.  Increase in [3H]nitrendipine binding sites in the brain in morphine-tolerant mice. , 1984, European journal of pharmacology.

[95]  P. Greengard,et al.  Protein Phosphorylation and Neuronal Function , 1985, Journal of neurochemistry.

[96]  J. Putney,et al.  A model for receptor-regulated calcium entry. , 1986, Cell calcium.

[97]  R. Miller,et al.  Protein kinase C mediated regulation of calcium channels in PC-12 pheochromocytoma cells. , 1986, Biochemical and biophysical research communications.

[98]  J. Bosso,et al.  Tetany associated with nifedipine. , 1986, The New England journal of medicine.

[99]  S. M. Goldin,et al.  Calcium channels in rat brain synaptosomes: identification and pharmacological characterization. High affinity blockade by organic Ca2+ channel blockers , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[100]  I. Hanbauer,et al.  Evidence for down-regulation of 3H-nitrendipine recognition sites in mouse brain after long-term treatment with nifedipine or verapamil , 1985, Neuropharmacology.

[101]  R. Anderson,et al.  Selective central nervous system calcium channel blockers--a new class of anticonvulsant agents. , 1986, Mayo Clinic proceedings.

[102]  P. Greengard,et al.  Enhancement of calcium current in Aplysia neurones by phorbol ester and protein kinase C , 1985, Nature.

[103]  L. Salkoff,et al.  Occult Drosophila calcium channels and twinning of calcium and voltage-activated potassium channels , 1986, Science.

[104]  D. Greenberg,et al.  Inhibition of calcium flux and calcium channel antagonist binding in the PC12 neural cell line by phorbol esters and protein kinase C. , 1986, Biochemical and biophysical research communications.

[105]  A. Wyler,et al.  Mechanisms underlying epileptiform burst discharge , 1980, Annals of neurology.

[106]  A. Ullrich,et al.  The complete primary structure of protein kinase C--the major phorbol ester receptor. , 1986, Science.

[107]  S. Snyder,et al.  [3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[108]  R. Eckert,et al.  Inactivation of Ca channels. , 1984, Progress in biophysics and molecular biology.

[109]  M. Jacobs,et al.  Diltiazem and akathisia. , 1983, Annals of internal medicine.

[110]  M. Spedding,et al.  Antagonism of Ca2+-induced contractions of K+-depolarized smooth muscle by local anaesthetics. , 1985, European journal of pharmacology.

[111]  B. Weir.  Calcium Antagonists, Cerebral Ischemia and Vasospasm , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[112]  V. Myllylä,et al.  Efficacy of Nimodipine in the Prophylaxis of Migraine , 1985, Cephalalgia : an international journal of headache.

[113]  C. Binnie,et al.  Open Dose‐Ranging Trial of Flunarizine as Add‐On Therapy in Epilepsy , 1985, Epilepsia.

[114]  T. Wang,et al.  Presynaptic calcium channels in rat cortical synaptosomes: fast- kinetics of phasic calcium influx, channel inactivation, and relationship to nitrendipine receptors , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[115]  J. Meyer,et al.  Clinical Effectiveness of Calcium Entry Blockers in Prophylactic Treatment of Migraine and Cluster Headaches , 1983, Headache.

[116]  R. Macdonald,et al.  Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. , 1985, The Journal of pharmacology and experimental therapeutics.

[117]  T. Perney,et al.  Multiple calcium channels mediate neurotransmitter release from peripheral neurons. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[118]  Michael J. Berridge,et al.  Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.

[119]  G. Fischbach,et al.  Neurotransmitters decrease the calcium component of sensory neurone action potentials , 1978, Nature.

[120]  R. Gould,et al.  Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine , 1985, Brain Research.

[121]  R. Llinás,et al.  Are the presynaptic membrane particles the calcium channels? , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[122]  R. Miller,et al.  The effects of dihydropyridines on neurotransmitter release from cultured neuronal cells. , 1984, Life sciences.

[123]  G. Allen,et al.  Relative Potency and Selectivity of Calcium Antagonists Used in the Treatment of Migraine , 1984, Headache.

[124]  J D Michenfelder,et al.  Nimodipine Improves Cerebral Blood Flow and Neurologic Recovery after Complete Cerebral Ischemia in the Dog , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[125]  D. Greenberg,et al.  Inactivation of 45Ca2+ uptake by prior depolarization of PC12 cells , 1985, Neuroscience Letters.

[126]  J D Michenfelder,et al.  Nimodipine Improves Outcome when Given after Complete Cerebral Ischemia in Primates , 1985, Anesthesiology.

[127]  F. Orrego,et al.  Kainate, N-methylaspartate and other excitatory amino acids increase calcium influx into rat brain cortex cells in vitro , 1983, Neuroscience Letters.

[128]  D. Kendall,et al.  Receptors and phosphoinositide metabolism in the central nervous system. , 1986, Biochemical pharmacology.

[129]  S. Peroutka,et al.  The Pharmacology of Calcium Channel Antagonists: a Novel Class of Anti‐migraine Agents? , 1983, Headache.

[130]  J. Cheung,et al.  Calcium and ischemic injury. , 1986, The New England journal of medicine.

[131]  H. Gerschenfeld,et al.  Two different mechanisms of calcium spike modulation by dopamine , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[132]  T. Bolton.  Mechanisms of action of transmitters and other substances on smooth muscle. , 1979, Physiological reviews.

[133]  A. Palant,et al.  Muscle cramps during treatment with nifedipine. , 1982, British medical journal.

[134]  N. Dun,et al.  Prostaglandin E1 inhibits calcium-dependent potentials in mammalian sympathetic neurons , 1985, Brain Research.

[135]  D. Greenberg.  Calcium channel antagonists and the treatment of migraine. , 1986, Clinical neuropharmacology.

[136]  W. N. Ross,et al.  Regional distribution of calcium influx into bursting neurons detected with arsenazo III. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[137]  R. Tsien,et al.  Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[138]  H. Yamamura,et al.  High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart. , 1984, Life sciences.

[139]  M. Delay,et al.  Inositol 1,4,5-trisphosphate: a possible chemical link in excitation-contraction coupling in muscle. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[140]  R. Kelly,et al.  Biochemistry of neurotransmitter release. , 1979, Annual review of neuroscience.

[141]  J. Hume,et al.  Actions of phencyclidine on the action potential and membrane currents of single guinea-pig myocytes. , 1986, The Journal of pharmacology and experimental therapeutics.

[142]  J. B. Macdonald.  Muscle cramps during treatment with nifedipine. , 1982, British medical journal.

[143]  E. Delpont,et al.  [3H]nitrendipine receptors in skeletal muscle. , 1983, The Journal of biological chemistry.

[144]  L. Toll.  Calcium antagonists High-affinity binding and inhibition of calcium transport in a clonal cell line. , 1982, The Journal of biological chemistry.

[145]  E. Kaplinsky,et al.  The Influence of Verapamil on Serum Digoxin Concentration , 1982, Circulation.

[146]  A. Cm,et al.  Two distinct populations of calcium channels in a clonal line of pituitary cells. , 1985 .

[147]  H. Koenig,et al.  Polyamines appear to be second messengers in mediating Ca2+ fluxes and neurotransmitter release in potassium-depolarized synaptosomes. , 1985, Biochemical and biophysical research communications.

[148]  M. Lazdunski,et al.  Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes. , 1986, The Journal of biological chemistry.

[149]  B. Amor,et al.  Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon. , 1983, The New England journal of medicine.

[150]  Y. Nishizuka.  Studies and perspectives of protein kinase C. , 1986, Science.

[151]  M. Lazdunski,et al.  Different types of Ca2+ channels in mammalian skeletal muscle cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[152]  S. Snyder,et al.  Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[153]  M. Sturek,et al.  Calcium and sodium channels in spontaneously contracting vascular muscle cells. , 1986, Science.

[154]  Desmedt L.K.C.,et al.  Anticonvulsive properties of cinnarizine and flunarizine in rats and mice. , 1975 .

[155]  M. Mayer,et al.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones , 1984, Nature.

[156]  K. Murase,et al.  Substance P augments a persistent slow inward calcium-sensitive current in voltage-clamped spinal dorsal horn neurons of the rat , 1986, Brain Research.

[157]  P. Casaer,et al.  FLUNARIZINE IN ALTERNATING HEMIPLEGIA IN CHILDHOOD , 1984, The Lancet.

[158]  H. J. Gelmers.  The effects of nimodipine on the clinical course of patients with acute ischemic stroke , 1984, Acta neurologica Scandinavica.

[159]  W. Hoss,et al.  Tricyclic antidepressant inhibition of depolarization-induced uptake of calcium by synaptosomes from rat brain. , 1985, Biochemical pharmacology.

[160]  O. Wolkowitz,et al.  Verapamil concentrations in cerebrospinal fluid after oral administration. , 1985, The New England journal of medicine.

[161]  N. Spitzer,et al.  The absence of calcium blocks impulse-evoked release of acetylcholine but not de novo formation of functional neuromuscular synaptic contacts in culture , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[162]  G. Belz,et al.  DIGOXIN PLASMA CONCENTRATIONS AND NIFEDIPINE , 1981, The Lancet.

[163]  L. Brandt,et al.  Delayed ischemic deterioration in patients with early aneurysm operation and intravenous nimodipine. , 1986, Neurosurgery.

[164]  R. Tsien,et al.  Three types of neuronal calcium channel with different calcium agonist sensitivity , 1985, Nature.

[165]  H. Hatanaka,et al.  Neuronal differentiation of Ca2+ channel by nerve growth factor , 1985, Brain Research.

[166]  F. Virgilio,et al.  Inositol 1,4,5-trisphosphate induces calcium release from sarcoplasmic reticulum of skeletal muscle , 1985, Nature.

[167]  R. Miller,et al.  Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[168]  G. Powis,et al.  Anthracycline-induced inhibition of a calcium action potential in differentiated murine neuroblastoma cells. , 1986, Cancer research.

[169]  B. Bean.  Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology , 1985, The Journal of general physiology.

[170]  S. Snyder,et al.  Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects. , 1985 .

[171]  M. Morad,et al.  Two types of calcium channels in guinea pig ventricular myocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[172]  H. Reuter,et al.  Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[173]  B. Bean.  Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[174]  A. Ullrich,et al.  Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. , 1986, Science.

[175]  D. Triggle,et al.  BAY K 8644, a 1,4‐Dihydropyridine Ca2+ Channel Activator: Dissociation of Binding and Functional Effects in Brain Synaptosomes , 1984, Journal of Neurochemistry.

[176]  A. Fleckenstein.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.

[177]  W. Catterall,et al.  Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. , 1984, Biochemistry.

[178]  F. Di Virgilio,et al.  Tumor promoter phorbol myristate acetate inhibits Ca2+ influx through voltage-gated Ca2+ channels in two secretory cell lines, PC12 and RINm5F. , 1986, The Journal of biological chemistry.

[179]  A. Brown,et al.  The agonist effect of dihydropyridines on Ca channels , 1984, Nature.

[180]  G. Weissmann,et al.  Stimulus-response coupling in sponge cell aggregation: Evidence for calcium as an intracellular messenger. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[181]  D. Greenberg,et al.  Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells. , 1986, The Journal of pharmacology and experimental therapeutics.

[182]  R. Heros,et al.  Cerebral vasospasm after subarachnoid hemorrhage: An update , 1983, Annals of neurology.